argenx SE (EBR:ARGX)
784.40
+2.60 (0.33%)
Jun 26, 2026, 5:39 PM CET
argenx SE Employees
argenx SE had 1,863 employees as of December 31, 2025. The number of employees increased by 264 or 16.51% compared to the previous year.
Employees
1,863
Change (1Y)
264
Growth (1Y)
16.51%
Revenue / Employee
€2,207,806
Profits / Employee
€693,205
Market Cap
48.78B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 9,765 |
| Onward Medical | 137 |
| Hyloris Pharmaceuticals | 55 |
| European Medical Solutions | 127 |
| Celyad Oncology | 5 |
| BioSenic | 7 |
| Oxurion NV | 26 |
argenx SE News
- 1 day ago - ARGX Reiterates by HC Wainwright & Co. -- Price Target Maintained at $940 - GuruFocus
- 2 days ago - ARGX Maintained by Morgan Stanley -- Price Target Raised to $1180 - GuruFocus
- 2 days ago - Can Argenx Retake Its Record High — And A Buy Point — On A New Vyvgart Strategy? - Investor's Business Daily
- 2 days ago - Argenx price target raised to $1,180 from $1,170 at Morgan Stanley - TheFly
- 3 days ago - argenx SE Transcript: Status update - Transcripts
- 15 days ago - argenx Eyes More VYVGART Growth as Pipeline Catalysts Near - MarketBeat
- 17 days ago - argenx SE Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 22 days ago - argenx Touts VYVGART Growth, 50,000-Patient Goal at William Blair Conference - MarketBeat